Aurobindo Pharma informs about integrated filing

07 Feb 2025 Evaluate

Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No.20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, Aurobindo Pharma has submitted the Integrated Filing (Financial) for the quarter and nine months period ended December 31, 2024. The aforesaid Integrated Filing (Financial) is also being updated on the website of the Company at https://www.aurobindo.com/.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1168.90 -43.40 (-3.58%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×